glp-1 meaning Can one drug do it all? Reviewing the expanding clinical universe of agonists GLP-1 | Summary

Meyer A, Eskandari S, Grallath S et al (2006) AtGAT1, a High Affinity Transporter for -Aminobutyric Acid in Arabidopsis thaliana

Their studies established that GLP-1 signaling enhances oxidant capacity, which successively escalates fatty acid oxidation within cultured adipocytes

The promising role of antioxidant phytochemicals in the prevention and treatment of periodontal disease via the inhibition of oxidative stress pathways: Updated insights

Becker KL, Ferguson RH, McConahey WM

Methods Study design Representatives of the companies Bristol-Myers Squibb, Novo Nordisk, Sanofi, Merck, Novartis, Boehringer Ingelheim and Takeda were contacted with the request to provide the event numbers of acute pancreatitis with the respective drug and non-incretin comparators as well as the corresponding number of patient-years of exposure (PYOs) for the approved GLP-1 receptor agonists exenatide twice daily, exenatide weekly, liraglutide and lixisenatide, as well as the DPP-4 inhibitors sitagliptin, saxagliptin, vildagliptin, alogliptin and linagliptin

This can lead to reduced daytime sleepiness, improved concentration, and an enhanced sense of well-being